tiprankstipranks
Sangui BioTech International Inc (SGBI)
OTHER OTC:SGBI
Holding SGBI?
Track your performance easily

Sangui BioTech International (SGBI) Financial Statements

3 Followers

Sangui BioTech International Financial Overview

Sangui BioTech International's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Sangui BioTech International is scheduled to report earnings on February 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 18.70K$ 10.63K$ 41.03K$ 10.50K$ 17.95K
Gross Profit$ 18.70K$ 10.63K$ 41.03K$ 10.50K$ 17.95K
EBIT$ -33.28K$ -98.25K$ 29.99K$ -4.41K$ -10.91K
EBITDA$ -28.45K$ -93.52K$ 34.65K$ 29.95K$ -14.76K
Net Income Common Stockholders$ -38.19K$ -207.73K$ 51.57K$ -21.91K$ -31.57K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.98K$ 9.31K$ 6.70K$ 30.47K$ 67.62K
Total Assets$ 89.10K$ 99.06K$ 127.47K$ 130.79K$ 186.01K
Total Debt$ 834.05K$ 830.53K$ 763.76K$ 825.00K$ 877.99K
Net Debt$ 827.07K$ 821.21K$ 757.06K$ 794.53K$ 810.38K
Total Liabilities$ 1.10M$ 1.07M$ 988.97K$ 1.03M$ 1.08M
Stockholders Equity$ -354.33K$ -314.93K$ -207.38K$ -239.13K$ -238.41K
Cash Flow-
Free Cash Flow$ 251.00$ 4.90K$ -25.69K$ -21.30K$ -40.82K
Operating Cash Flow$ 251.00$ 4.90K$ -25.69K$ -21.30K$ -24.77K
Investing Cash Flow$ -4.00K$ -3.74K$ -3.67K$ -33.28K$ 4.95K
Financing Cash Flow$ -2.90K$ -2.72K$ -2.65K$ -1.31K$ 85.34K
Currency in USD

Sangui BioTech International Earnings and Revenue History

Sangui BioTech International Debt to Assets

Sangui BioTech International Cash Flow

Sangui BioTech International Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis